Relapsing Polychondritis and Aseptic Meningoencephalitis

Intern Med. 2023 Feb 1;62(3):481-486. doi: 10.2169/internalmedicine.9411-22. Epub 2022 Jul 14.

Abstract

We herein report a 49-year-old Japanese man with relapsing polychondritis (RP) and aseptic meningoencephalitis. Four years ago, the patient was diagnosed with RP. Prednisolone (PSL) was started at 30 mg/day, and the symptoms promptly disappeared. However, cognitive impairment gradually appeared from six months before hospitalization. Methylprednisolone pulse therapy was immediately initiated, followed by administration of PSL at 1 mg/kg/day. Intravenous cyclophosphamide was combined with PSL. After treatment, the patient's cognitive impairment clearly improved. In conclusion, RP rarely causes aseptic meningoencephalitis, highlighting the need for prompt and aggressive immunosuppressive therapy.

Keywords: aseptic meningoencephalitis; glucocorticoids; immunosuppressants; interleukin-6; relapsing polychondritis.

Publication types

  • Case Reports

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Male
  • Meningoencephalitis* / complications
  • Meningoencephalitis* / diagnosis
  • Meningoencephalitis* / drug therapy
  • Middle Aged
  • Polychondritis, Relapsing* / complications
  • Polychondritis, Relapsing* / diagnosis
  • Polychondritis, Relapsing* / drug therapy
  • Prednisolone / therapeutic use

Substances

  • Prednisolone
  • Cyclophosphamide